AsOf

Recorded or changed on this day 2026-11-08

2,301–2,350 of 46,540 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 87,897,000,000 United States dollar
Amgen total assets: 87,897,000,000 United States dollar, claim clm_A58542830DFC · ended · superseded by clm_A3A1C9D984F8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 7,722,000,000 United States dollar
Amgen net income: 7,722,000,000 United States dollar, claim clm_A5BF59D89483 · ended · superseded by clm_2C7BDDED6E27 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,805,000,000 United States dollar
Amgen cash and equivalents: 3,805,000,000 United States dollar, claim clm_A7F5983DB63E · ended · superseded by clm_85F128FF8BDF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,439,000,000 United States dollar
Amgen quarterly operating income: 2,439,000,000 United States dollar, claim clm_A7F81572ADB3 · ended · superseded by clm_9C5726C18879 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 725,910,575 shares
Amgen shares outstanding: 725,910,575 shares, claim clm_A8C70ACAF4DA · ended · superseded by clm_96402624AA53 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,526,000,000 United States dollar
Amgen quarterly operating income: 2,526,000,000 United States dollar, claim clm_A957F605C563 · ended · superseded by clm_8FA61AE28EA3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,457,000,000 United States dollar
Amgen quarterly operating income: 1,457,000,000 United States dollar, claim clm_A972FFF57CA8 · ended · superseded by clm_8A1A7F8B1FAB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,423,000,000 United States dollar
Amgen quarterly revenue: 6,423,000,000 United States dollar, claim clm_A9C5A1ACE96F · ended · superseded by clm_9E8DA72630EB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,059,000,000 United States dollar
Amgen quarterly revenue: 6,059,000,000 United States dollar, claim clm_AAF52E028DB6 · ended · superseded by clm_87A5042FAB0D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 589,806,819 shares
Amgen shares outstanding: 589,806,819 shares, claim clm_AB83B8B5713B · ended · superseded by clm_D739E45E5467 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,730,000,000 United States dollar
Amgen quarterly net income: 1,730,000,000 United States dollar, claim clm_ABB59844DF49 · ended · superseded by clm_B66FDC24597B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 5,925,000,000 United States dollar
Amgen total equity: 5,925,000,000 United States dollar, claim clm_AC23A926EFAF · ended · superseded by clm_A4EA1DDC1704 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,812,000,000 United States dollar
Amgen quarterly revenue: 3,812,000,000 United States dollar, claim clm_AC30B5A349EC · ended · superseded by clm_0468DD568B92 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 758,250,346 shares
Amgen shares outstanding: 758,250,346 shares, claim clm_AC443719191E · ended · superseded by clm_7E3142F8191A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,896,000,000 United States dollar
Amgen cash and equivalents: 2,896,000,000 United States dollar, claim clm_AC822552ABB6 · ended · superseded by clm_E0A3DD098E3C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 748,430,018 shares
Amgen shares outstanding: 748,430,018 shares, claim clm_ACDCA67E4AE4 · ended · superseded by clm_E3B8A2E816E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,481,000,000 United States dollar
Amgen quarterly operating income: 1,481,000,000 United States dollar, claim clm_AD3F260E35C2 · ended · superseded by clm_14CFAC59EFA9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 34,248,000,000 United States dollar
Amgen cash and equivalents: 34,248,000,000 United States dollar, claim clm_ADA1FFC461F7 · ended · superseded by clm_49C1DCF00977 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,472,000,000 United States dollar
Amgen quarterly operating income: 2,472,000,000 United States dollar, claim clm_ADA46DB14C4E · ended · superseded by clm_352EE42890C4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 20,885,000,000 United States dollar
Amgen total equity: 20,885,000,000 United States dollar, claim clm_AF67FFE7C117 · ended · superseded by clm_BF452CEA40BB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 11,973,000,000 United States dollar
Amgen cash and equivalents: 11,973,000,000 United States dollar, claim clm_B08ED03B8CC3 · ended · superseded by clm_089D9CECF18D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,688,000,000 United States dollar
Amgen quarterly operating income: 1,688,000,000 United States dollar, claim clm_B0A9F616BD13 · ended · superseded by clm_1C381C3663B1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,522,000,000 United States dollar
Amgen cash and equivalents: 2,522,000,000 United States dollar, claim clm_B0CE0DC6AD30 · ended · superseded by clm_10C37649975D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,236,000,000 United States dollar
Amgen quarterly net income: 1,236,000,000 United States dollar, claim clm_B0E17E7BDD6B · ended · superseded by clm_D713C582BE0E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 4,679,000,000 United States dollar
Amgen quarterly revenue: 4,679,000,000 United States dollar, claim clm_B14B41207FDF · ended · superseded by clm_3033018610D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,184,000,000 United States dollar
Amgen quarterly net income: 1,184,000,000 United States dollar, claim clm_B28859B14384 · ended · superseded by clm_376CEF6833C7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 10,832,000,000 United States dollar
Amgen total equity: 10,832,000,000 United States dollar, claim clm_B43E99166EDA · ended · superseded by clm_15DDEC9FE673 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,432,000,000 United States dollar
Amgen quarterly net income: 1,432,000,000 United States dollar, claim clm_B66FDC24597B · ended · superseded by clm_E7FF81925833 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 14,642,000,000 United States dollar
Amgen revenue: 14,642,000,000 United States dollar, claim clm_B7B415A6CD44 · ended · superseded by clm_21002187AEE3 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · quarterly operating income · 3,710,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,021,000,000 United States dollar
Amgen quarterly net income: 2,021,000,000 United States dollar, claim clm_B82AB1C3159B · ended · superseded by clm_0C7BF65A9CC8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,386,000,000 United States dollar
Amgen quarterly net income: 1,386,000,000 United States dollar, claim clm_B8CC66F883EA · ended · superseded by clm_9969F416755C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,819,000,000 United States dollar
Amgen quarterly net income: 1,819,000,000 United States dollar, claim clm_B9855476A1FF · ended · superseded by clm_159BCD3BFBBD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 8,618,000,000 United States dollar
Amgen quarterly revenue: 8,618,000,000 United States dollar, claim clm_BA3B03AF2A85 · ended · superseded by clm_EE4AA58E7ACE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 557,029,370 shares
Amgen shares outstanding: 557,029,370 shares, claim clm_BA677DC55A32 · ended · superseded by clm_F932B282715C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,992,000,000 United States dollar
Amgen quarterly net income: 1,992,000,000 United States dollar, claim clm_BA7043500A6A · ended · superseded by clm_206CA4F50FEA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,287,000,000 United States dollar
Amgen cash and equivalents: 3,287,000,000 United States dollar, claim clm_BBB0BE58C057 · ended · superseded by clm_8218A755F248 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 3,078,000,000 United States dollar
Amgen net income: 3,078,000,000 United States dollar, claim clm_BBC1534096ED · ended · superseded by clm_4826D0123EC0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 64,993,000,000 United States dollar
Amgen total assets: 64,993,000,000 United States dollar, claim clm_BD51A9765CB0 · ended · superseded by clm_43D551B4FBB5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,502,000,000 United States dollar
Amgen cash and equivalents: 9,502,000,000 United States dollar, claim clm_BDE07F9B7128 · ended · superseded by clm_9441264854A2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,731,000,000 United States dollar
Amgen cash and equivalents: 3,731,000,000 United States dollar, claim clm_BEC2DEF69723 · ended · superseded by clm_596A841E23FE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,355,000,000 United States dollar
Amgen quarterly operating income: 2,355,000,000 United States dollar, claim clm_BEF30CEEC59D · ended · superseded by clm_CCCD3C3FB13D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 29,875,000,000 United States dollar
Amgen total equity: 29,875,000,000 United States dollar, claim clm_BF0D3030F73E · ended · superseded by clm_DD2379CF3330 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,368,000,000 United States dollar
Amgen quarterly net income: 1,368,000,000 United States dollar, claim clm_BF2B62C3B6C9 · ended · superseded by clm_2AFFA5A382C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 5,893,000,000 United States dollar
Amgen net income: 5,893,000,000 United States dollar, claim clm_BF2E5D6BD634 · ended · superseded by clm_C644E157DE79 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 21,360,000,000 United States dollar
Amgen total equity: 21,360,000,000 United States dollar, claim clm_BF452CEA40BB · ended · superseded by clm_D33321EF3A62 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 6,700,000,000 United States dollar
Amgen total equity: 6,700,000,000 United States dollar, claim clm_BF8A71350904 · ended · superseded by clm_68A37D10302E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 8,503,000,000 United States dollar
Amgen quarterly revenue: 8,503,000,000 United States dollar, claim clm_BF9D0F8819AD · ended · superseded by clm_FD554405E740 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,033,000,000 United States dollar
Amgen quarterly revenue: 5,033,000,000 United States dollar, claim clm_C0A999C2E5DE · ended · superseded by clm_28F3330C360C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,713,000,000 United States dollar
Amgen quarterly revenue: 3,713,000,000 United States dollar, claim clm_C0FD4A4DBDE5 · ended · superseded by clm_AC30B5A349EC · 1 source (1 primary) · conf 0.95

What the statuses mean